Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Tecentriq
Tecentriq
Roche scores adjuvant lung cancer approval for Tecentriq
Pharmaforum
Mon, 10/18/21 - 11:00 am
Roche
Tecentriq
FDA
non-small cell lung cancer
Roche's Tecentriq crosses the finish line first in adjuvant lung cancer, potentially kicking off gold rush
Endpoints
Fri, 10/15/21 - 10:37 pm
Roche
Tecentriq
non-small cell lung cancer
FDA
ESMO: Exelixis lays out promising early Cabometyx combo data in prostate cancer, but key discrepancies persist
Fierce Pharma
Sat, 09/18/21 - 08:27 pm
ESMO
Exelixis
Cabometyx
Roche
Tecentriq
clinical trials
prostate cancer
Roche to withdraw US accelerated approval for Tecentriq to treat breast cancer
Pharmaceutical Business Review
Mon, 08/30/21 - 10:42 am
Roche
Tecentriq
Abraxane
triple negative breast cancer
FDA
accelerated approval
Roche pulls Tecentriq breast cancer nod after post-approval trial flop
Fierce Pharma
Sat, 08/28/21 - 09:04 pm
Roche
Tecentriq
breast cancer
triple negative breast cancer
postmarketing studies
Analysts throw cold water on Exelixis and Roche's prostate cancer data, putting the pair a further step behind Novartis
Endpoints
Tue, 05/25/21 - 11:08 am
Exelixis
Cabometyx
Roche
Tecentriq
prostate cancer
Merck, Roche and Bristol Myers nab 4 of 6 positive ODAC votes for ‘dangling’ accelerated approvals
Endpoints
Thu, 04/29/21 - 10:55 pm
Merck
Roche
Bristol Myers Squibb
FDA
ODAC
accelerated approvals
Keytruda
Opdivo
Tecentriq
ODAC votes to keep Keytruda and Tecentriq accelerated approvals in bladder cancer
Endpoints
Wed, 04/28/21 - 10:12 pm
FDA
ODAC
accelerated approvals
Merck
Keytruda
Roche
Tecentriq
FDA panel questions Roche’s Tecentriq-Abraxane combo in breast cancer, but votes to keep approval in place for now
Fierce Pharma
Tue, 04/27/21 - 11:37 pm
Roche
Tecentriq
Abraxane
breast cancer
FDA
accelerated approvals
What are Merck, Bristol Myers and Roche planning for the big FDA cancer approval review?
Fierce Pharma
Tue, 04/27/21 - 11:04 am
FDA
oncology
accelerated approvals
Merck
Keytruda
Bristol Myers Squibb
Opdivo
Roche
Tecentriq
FDA Advisory Committee to Review Checkpoint Inhibitors Greenlit Under Accelerated Approval
BioSpace
Sun, 04/25/21 - 01:56 pm
FDA
oncology
cancer
accelerated approvals
Bristol Myers Squibb
Opdivo
Roche
Tecentriq
Merck
Keytruda
Roche's Tecentriq is the first I-O drug to claim a post-surgery win in lung cancer. But will doctors use it?
Fierce Pharma
Mon, 03/22/21 - 10:48 am
Roche
Tecentriq
non-small cell lung cancer
Roche joins the FDA accelerated approval revamp team, nixing a Tecentriq bladder cancer nod
Fierce Pharma
Mon, 03/8/21 - 11:12 am
Roche
Tecentriq
bladder cancer
Roche gets FDA breakthrough therapy status for tiragolumab plus Tecentriq
Pharmaceutical Business Review
Wed, 01/6/21 - 10:37 am
Roche
FDA
tiragolumab
Tecentriq
non-small cell lung cancer
breakthrough therapies
Merck, Bristol Myers, AstraZeneca and Roche lose bid to expand PD-1/L1 reach in China
Fierce Pharma
Wed, 12/30/20 - 10:53 am
Merck
Bristol-Myers Squibb
AstraZeneca
Roche
Keytruda
Opdivo
Imfinzi
Tecentriq
China
PD-1 inhibitors
ESMO: Roche's mixed results put Tecentriq's triple-negative breast cancer use into question
Fierce Pharma
Sun, 09/20/20 - 07:57 pm
ESMO
Roche
Tecentriq
triple negative breast cancer
Merck
Keytruda
FDA puts Roche's Tecentriq under the lens in breast cancer after recent trial flop
Fierce Pharma
Wed, 09/9/20 - 08:05 pm
Roche
Tecentriq
triple negative breast cancer
paclitaxel
clinical trials
FDA
In surprising setback, combo of Roche’s Tecentriq and chemo fails to help patients with triple-negative breast cancer
Endpoints
Fri, 08/7/20 - 10:56 am
Roche
FDA
triple negative breast cancer
Tecentriq
FDA approves Roche’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanoma
Pharmaceutical Business Review
Mon, 08/3/20 - 10:33 am
Roche
FDA
Tecentriq
Cotellic
Zelboraf
melanoma
Roche’s Tecentriq claims melanoma OK, but don’t expect a sales surge
Pharmaforum
Fri, 07/31/20 - 10:43 am
Roche
Tecentriq
FDA
melanoma
Bristol-Myers Squibb
Merck
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »